Citigroup »

Cortexyme shares owned by Citigroup

Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Cortexyme

Tip: Access up to 7 years of quarterly data

All positions including Cortexyme held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cortexyme by Citigroup

Quarter filed Position value Share count Share price at filing
2024-09-30 $13k 17k 0.78
2024-06-30 $3.9k 5.2k 0.75
2024-03-31 $5.5k 5.2k 1.06
2023-12-31 $5.4k 5.2k 1.05
2023-09-30 $5.8k 5.2k 1.12
2023-03-31 $8.1k 5.2k 1.56
2022-12-31 $3.3k 5.2k 0.64
2022-09-30 $7.0k 5.6k 1.26
2021-12-31 $207k 16k 12.59
2021-03-31 $2.4M 67k 36.03
2020-12-31 $118k 4.2k 27.83
2020-09-30 $45k 909 49.51
2020-06-30 $654k 14k 46.27
2020-03-31 $158k 3.5k 45.53
2019-12-31 $130k 2.3k 56.20
2019-09-30 $4.1k 143 28.99
2019-06-30 $34k 805 42.39